Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Hsieh

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 15, 2005
Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolitesTeresa Pekol, J Scott Daniels, Jason Labutti, et al.
Arthritis Research & Therapy|November 1, 2014
Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)William P Kennedy, J Abraham Simon, Carolyn Offutt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2022
Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson DiseaseMatthew Surface, Manisha Balwani, Cheryl Waters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2021
Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's DiseaseMatthew Surface, Manisha Balwani, Cheryl Waters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 18, 2022
Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?Matthew Surface, Manisha Balwani, Cheryl Waters, et al.
The Journal of Biological Chemistry|January 30, 2002
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidaseChad Vickers, Paul Hales, Virendar Kaushik, et al.
Elife|April 2, 2026
Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and glucocerebrosidase activityElsa Meneses-Salas, Moises Castellá, Marianna Arnold, et al.
Nature Protocols|June 10, 2026
Robust analytical methods for bis(monoacylglycero)phosphate profiling in health and diseaseWentao Dong, Kwamina Nyame, Eshaan S Rawat, et al.
The New England Journal of Medicine|March 22, 2002
A controlled trial of inpatient and outpatient geriatric evaluation and managementHarvey Jay Cohen, John R Feussner, Morris Weinberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2007
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft toleranceSophie Brouard, Elaine Mansfield, Christophe Braud, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 15, 2005
Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolitesTeresa Pekol, J Scott Daniels, Jason Labutti, et al.
Arthritis Research & Therapy|November 1, 2014
Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)William P Kennedy, J Abraham Simon, Carolyn Offutt, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2022
Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson DiseaseMatthew Surface, Manisha Balwani, Cheryl Waters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2021
Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's DiseaseMatthew Surface, Manisha Balwani, Cheryl Waters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 18, 2022
Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?Matthew Surface, Manisha Balwani, Cheryl Waters, et al.
The Journal of Biological Chemistry|January 30, 2002
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidaseChad Vickers, Paul Hales, Virendar Kaushik, et al.
Elife|April 2, 2026
Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and glucocerebrosidase activityElsa Meneses-Salas, Moises Castellá, Marianna Arnold, et al.
Nature Protocols|June 10, 2026
Robust analytical methods for bis(monoacylglycero)phosphate profiling in health and diseaseWentao Dong, Kwamina Nyame, Eshaan S Rawat, et al.
The New England Journal of Medicine|March 22, 2002
A controlled trial of inpatient and outpatient geriatric evaluation and managementHarvey Jay Cohen, John R Feussner, Morris Weinberger, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2007
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft toleranceSophie Brouard, Elaine Mansfield, Christophe Braud, et al.
Pageof 6